Rigel Pharmaceuticals Inc (RIGL)
0.9504
-0.03
(-3.27%)
USD |
NASDAQ |
May 17, 16:00
1.02
+0.07
(+7.32%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Operations (Quarterly): -5.013M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -5.013M |
December 31, 2023 | -6.24M |
September 30, 2023 | -1.359M |
June 30, 2023 | 5.93M |
March 31, 2023 | -4.074M |
December 31, 2022 | -21.91M |
September 30, 2022 | -13.30M |
June 30, 2022 | -12.91M |
March 31, 2022 | -25.64M |
December 31, 2021 | -19.09M |
September 30, 2021 | -10.30M |
June 30, 2021 | 55.22M |
March 31, 2021 | -19.96M |
December 31, 2020 | -15.57M |
September 30, 2020 | -19.48M |
June 30, 2020 | -14.04M |
March 31, 2020 | -3.093M |
December 31, 2019 | -9.649M |
September 30, 2019 | -14.64M |
June 30, 2019 | -16.65M |
March 31, 2019 | -0.569M |
December 31, 2018 | 11.64M |
September 30, 2018 | -20.08M |
June 30, 2018 | -26.99M |
March 31, 2018 | -23.39M |
Date | Value |
---|---|
December 31, 2017 | -19.72M |
September 30, 2017 | -17.61M |
June 30, 2017 | -19.47M |
March 31, 2017 | -20.76M |
December 31, 2016 | -12.46M |
September 30, 2016 | -22.57M |
June 30, 2016 | -18.43M |
March 31, 2016 | -22.42M |
December 31, 2015 | -13.80M |
September 30, 2015 | -9.457M |
June 30, 2015 | -18.15M |
March 31, 2015 | 17.99M |
December 31, 2014 | -15.00M |
September 30, 2014 | -18.38M |
June 30, 2014 | -19.94M |
March 31, 2014 | -16.43M |
December 31, 2013 | -18.90M |
September 30, 2013 | -20.74M |
June 30, 2013 | -21.32M |
March 31, 2013 | -25.11M |
December 31, 2012 | -21.57M |
September 30, 2012 | -19.62M |
June 30, 2012 | -20.74M |
March 31, 2012 | -23.27M |
December 31, 2011 | -18.65M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.64M
Minimum
Mar 2022
55.22M
Maximum
Jun 2021
-8.588M
Average
-13.11M
Median
Cash from Operations (Quarterly) Benchmarks
Nektar Therapeutics | -47.89M |
Avid Bioservices Inc | 3.687M |
Stereotaxis Inc | -2.346M |
Cara Therapeutics Inc | -30.45M |
Ardelyx Inc | -35.72M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 0.313M |
Cash from Financing (Quarterly) | -2.512M |
Free Cash Flow | -6.82M |
Free Cash Flow Per Share (Quarterly) | -0.0294 |
Free Cash Flow to Equity (Quarterly) | -5.239M |
Free Cash Flow Yield | -4.11% |